panel top
Almeta logo
bullet Our Company
bullet Our Businesses
bullet Horticulture
bullet Construction
bullet Consumer Items
bullet Healthcare

partner_cadila
Cadila Pharmaceuticals Ethiopia PLC (CPEL) is a joint venture between Cadila Pharmaceuticals Limited PLC of India and Almeta Impex PLC. CPEL is one of the few large state of the art pharmaceuticals manufacturing plants in the country, with the Capacity to manufacture 390 million tablets, 165 million capsules and 1.44 million liters per liter per year in 3 shifts of 8hours each.

“The aim of this joint-venture is to make a remarkable difference in the lives of the Ethiopian people by providing them with healthcare solutions of the highest quality at affordable prices and a guaranteed supply, thus carving a distinct identity at all levels”

Exports to COMESA states and other African countries will also be facilitated from the plant here in Ethiopia.

CPEL mainly focuses on the therapeutic areas such as Cardiovascular, Anti Diabetes Gastroenterology (anti-acids, anti-ulceractive), Anti–Infective, Anti–Depressants, Anti–Fungal, Anti–TB, Anti–Malarial, Anti–Retroviral, Anti–Amoebic, Haematinics, Anti – Allergic, Pain Killers, Multi-Vitamins etc.

This manufacturing facility has been approved by the Drug Administration and Control Authority (DACA) and conforms to GMP standards.

about_cadila

Cadila India enjoys an enviable reputation as a leading pharmaceutical company with a heritage of 56 years. Over the last five decades, it has been developing and manufacturing pharmaceutical products in India and selling and distributing them in India and in over 50 other countries around the world. The company focuses on providing high quality, appropriately priced products to its customers and supports all these with dedicated customer service.

Cadila India has state-of-art manufacturing facilities conforming to the most stringent international cGMP norms vis-à-vis WHO-GMP, WHO, Geneva (GDF site for Anti-TB), TGA Australia, USFDA, UK – MHRA, MCC – South Africa, ISO 9001 and ISO 14001. It's Dholka manufacturing facility is the cynosure of all eyes, fully equipped with world-class production facilities. The company’s two API units at Ankleshwar manufacture a wide-range of APIs and intermediates including many USFDA certified products. The manufacturing facility at Samba, near Jammu, which started its commercial operations in August 2006, is at par with other facilities of Cadila.

Cadila India’s present branded generic product portfolio comprises of more than 1000 product registrations across continents. Its widespread network of wholly owned subsidiary companies and marketing offices is spread over 87 countries across America, Africa, Asia, Europe, CIS and the Middle East. Through state-of-the-art manufacturing facilities and strategic business alliances with word leaders, Cadila India, is now poised for expansion of operations in regulated markets.





cadila_addis

cadila_addis

cadila_addis

cadila_addis

cadila_addis

cadila_addis


 > Cadila Pharmaceuticals Ltd.


© 2008 Almeta Impex. All Rights Reserved. Almeta, the Almeta logo and all brand names, company names, service marks, logos and trade dress of Almeta or its subsidiaries, affiliates or licensors are trademarks or registered trademarks of Almeta Impex Plc. or its subsidiaries, affiliates or licensors.